Interventional Tumor Ablation Global Market Report 2025
상품코드:1760573
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
중재적 종양 절제술 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 연조직 및 전이성 종양의 발병률 증가, 개인 맞춤형 암 치료 전략에 대한 관심 증가, 비수술적 종양 치료 옵션에 대한 수요 증가, 비용 효율적인 종양 치료로 전환, 첨단 절제 기기의 파이프라인 확대에 기인할 수 있습니다. 예측 기간에 예상되는 주요 동향으로는 복합 치료법 개발, 하이브리드 절제술의 개발, 절제술과 데이터 분석의 통합, 종양별 나노 절제술의 혁신, 절제술 시스템 기술의 발전 등이 있습니다.
암의 유병률이 증가함에 따라 가까운 미래에 중재적 종양 절제술 시장의 성장이 크게 가속화될 것으로 예상됩니다. 암은 신체에서 비정상적인 세포가 통제되지 않고 증식 및 확산되는 질병으로, 주변 조직을 침범하고 혈액 및 림프계를 통해 전이될 가능성이 있습니다. 암 발병 건수가 증가하는 주요 원인은 흡연, 불량한 식습관, 비만, 발암 물질에 대한 노출 등 생활 습관 및 환경적 요인에 기인합니다. 중재적 종양 절제술은 최소 침습적 기술을 통해 암 치료를 개선하고 환자에게 수술의 대안을 제공합니다. 이러한 방법은 종양을 정밀하게 파괴하여 치료 시간과 회복 기간을 단축함으로써 환자의 치료 결과와 전반적인 삶의 질을 개선합니다. 호주에서 암 진단 건수는 2022년에 16만 570건으로 증가하여 2021년 15만 6,781건에서 3,789건 증가했습니다.
중재적 종양 절제술 시장의 선도 기업들은 종양 절제술의 정확성과 효과를 개선하기 위해 BioTrace 소프트웨어 제품군과 같은 첨단 기술 솔루션의 개발에 주력하고 있습니다. BioTrace 소프트웨어 제품군은 특히 의료 및 연구 환경에서 생물학적 데이터를 추적, 관리 및 분석하기 위해 설계된 통합 도구입니다. 예를 들어, 2024년 7월, 이스라엘에 본사를 둔 의료 기기 회사인 TechsoMed Medical Technologies Ltd.는 영상 유도 간 종양 절제술의 치료를 개선하기 위해 BioTraceIO Vision 및 BioTraceIO Precision 소프트웨어 제품군을 출시했습니다. BioTraceIO Vision은 표준 의료 영상 기기를 사용하여 간 종양 절제술의 정확성과 효율성을 높이는 개인 맞춤형 치료 계획 및 평가를 위한 인공 지능(AI) 기반 도구를 통합합니다. 반면 BioTraceIO Precision은 시술 중 및 시술 후 실시간 초음파 기반 시각화 및 소작 구역의 예측 매핑을 제공하여 의료진이 조직 손상 및 치료 결과를 24시간 후 CT 스캔과 높은 상관관계로 평가할 수 있도록 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 중재적 종양 절제술: PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 중재적 종양 절제술 시장 : 성장률 분석
세계의 중재적 종양 절제술 시장 실적 : 규모와 성장(2019-2024년)
세계의 중재적 종양 절제술 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 중재적 종양 절제술 : 총 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 중재적 종양 절제술 시장 : 처치 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개복 수술
저침습 수술
영상 유도 개입
세계의 중재적 종양 절제술 시장 : 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
고주파 절제술(RFA)
마이크로파 절제술(MWA)
동결요법
레이저 절제술
고강도 초점식 초음파(HIFU)
세계의 중재적 종양 절제술 시장 : 디바이스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
절제술 시스템
소모품
지원 장치
이미징 시스템
세계의 중재적 종양 절제술 시장 : 응용 분야별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
간종양
신장 종양
폐종양
뼈종양
세계의 중재적 종양 절제술 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 암 치료 센터
외래수술센터(ASC)
연구기관
세계의 중재적 종양 절제술 시장 : 개복 수술 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
복강경하 종양 절제술
개흉 종양 절제술
세계의 중재적 종양 절제술 시장 : 저침습 수술 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경피 종양 절제술
내시경 절제술
세계의 중재적 종양 절제술 시장 : 영상 유도 개입 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
CT 가이드 종양 절제
자기 공명 영상 유도 종양 절제
초음파 가이드 종양 절제
제7장 지역별, 국가별 분석
세계의 중재적 종양 절제술 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 중재적 종양 절제술 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
중재적 종양 절제술 시장 : 경쟁 구도
중재적 종양 절제술 시장 : 기업 프로파일
Johnson And Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
EDAP TMS SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Stryker Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Boston Scientific Corporation
Olympus Corporation
Terumo Corporation
Hologic Inc.
Elekta
Commed Corporation
Bioventus Inc.
AtriCure
AngioDynamics Inc.
Mermaid Medical Group A/S
InSightec
Cascination AG
HS Hospital Service SpA
Theraclion
IceCure Medical Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
중재적 종양 절제술 시장(2029년) : 새로운 기회를 제공하는 국가
중재적 종양 절제술 시장(2029년) : 새로운 기회를 제공하는 부문
중재적 종양 절제술 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.
The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.
The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including the interventional tumor ablation industry's global market size, regional shares, competitors with the interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation market. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the increasing prevalence of liver and kidney cancers, greater awareness of minimally invasive cancer treatments, enhanced availability of diagnostic imaging, a growing geriatric population more susceptible to tumors, and a rising preference for outpatient procedures.
The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the rising incidence of soft tissue and metastatic tumors, an increasing focus on personalized cancer treatment strategies, growing demand for non-surgical tumor treatment options, a shift toward cost-effective tumor therapies, and an expanding pipeline of advanced ablation devices. Key trends expected in the forecast period include the development of combination therapies, the creation of hybrid ablation techniques, the integration of ablation with data analytics, innovations in tumor-specific nano-ablation, and advancements in ablation system technologies.
The increasing prevalence of cancer is expected to significantly boost the growth of the interventional tumor ablation market in the near future. Cancer, a group of diseases defined by the uncontrolled proliferation and spread of abnormal cells in the body, can invade surrounding tissues and potentially metastasize through the blood and lymphatic systems. The growing number of cancer cases is largely attributed to lifestyle and environmental factors such as smoking, poor diet, obesity, and exposure to carcinogens. Interventional tumor ablation improves cancer treatment by offering minimally invasive techniques, providing patients with an alternative to surgery. These methods shorten treatment time and recovery periods by allowing precise destruction of tumors, which improves patient outcomes and overall quality of life. For example, according to a July 2024 report from the Australian Institute of Health and Welfare, the number of cancer diagnoses in Australia increased to 160,570 in 2022, marking a rise of 3,789 cases from 156,781 in 2021. This growing cancer incidence is driving the expansion of the interventional tumor ablation market.
Leading companies in the interventional tumor ablation market are focusing on developing advanced technological solutions, such as the BioTrace software suite, to improve the precision and effectiveness of tumor ablation procedures. BioTrace software suites are integrated tools designed to track, manage, and analyze biological data, particularly in healthcare and research environments. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device company, introduced the BioTraceIO Vision and BioTraceIO Precision software suites, aimed at enhancing image-guided liver tumor ablation therapy. BioTraceIO Vision incorporates artificial intelligence (AI)-powered tools for personalized treatment planning and assessment, using standard medical imaging to boost the accuracy and efficiency of liver tumor ablation procedures. BioTraceIO Precision, on the other hand, provides real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after the procedure, helping clinicians evaluate tissue damage and treatment outcomes with high correlation to 24-hour post-ablation CT scans.
In February 2024, Immunophotonics Inc., a US-based biotechnology company, formed a partnership with AngioDynamics Inc. This collaboration aims to combine Immunophotonics' leading immunotherapy asset, IP-001, with AngioDynamics' ablation devices to explore the potential of combining ablation with immunotherapy in treating solid tumor cancers. AngioDynamics Inc., a US-based medical device company, offers microwave and radiofrequency ablation technologies for minimally invasive cancer treatment.
Major players in the interventional tumor ablation market are Johnson And Johnson, EDAP TMS S.A., Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Hologic Inc., Elekta, Conmed Corporation, Bioventus Inc., AtriCure, AngioDynamics Inc., Mermaid Medical Group A/S, InSightec, Cascination AG, H.S. Hospital Service S.p.A, Theraclion, IceCure Medical Ltd.
North America was the largest region in the interventional tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional tumor ablation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Interventional Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Procedure Type: Open Surgery; Minimally Invasive Surgery; Image-Guided Interventions
3. Interventional Tumor Ablation Market Trends And Strategies
4. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Interventional Tumor Ablation Growth Analysis And Strategic Analysis Framework
5.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Interventional Tumor Ablation Market Growth Rate Analysis
5.4. Global Interventional Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Interventional Tumor Ablation Total Addressable Market (TAM)
6.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Surgery
Minimally Invasive Surgery
Image-Guided Interventions
6.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency Ablation (RFA)
Microwave Ablation (MWA)
Cryoablation
Laser Ablation
High-Intensity Focused Ultrasound (HIFU)
6.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ablation Systems
Consumables
Support Devices
Imaging Systems
6.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liver Tumors
Kidney Tumors
Lung Tumors
Bone Tumors
6.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialized Cancer Treatment Centers
Ambulatory Surgical Centers
Research Institutes
6.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Open Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laparoscopic Tumor Ablation
Thoracotomy Tumor Ablation
6.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Percutaneous Tumor Ablation
Endoscopic Ablation
6.8. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Computed Tomography-Guided Tumor Ablation
Magnetic Resonance Imaging-Guided Tumor Ablation
Ultrasound-Guided Tumor Ablation
7. Interventional Tumor Ablation Market Regional And Country Analysis
7.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Interventional Tumor Ablation Market
9.1. China Interventional Tumor Ablation Market Overview
9.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Interventional Tumor Ablation Market
10.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Interventional Tumor Ablation Market
11.1. Japan Interventional Tumor Ablation Market Overview
11.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Interventional Tumor Ablation Market
12.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Interventional Tumor Ablation Market
13.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Interventional Tumor Ablation Market
14.1. South Korea Interventional Tumor Ablation Market Overview
14.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Interventional Tumor Ablation Market
15.1. Western Europe Interventional Tumor Ablation Market Overview
15.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Interventional Tumor Ablation Market
16.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Interventional Tumor Ablation Market
17.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Interventional Tumor Ablation Market
18.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Interventional Tumor Ablation Market
19.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Interventional Tumor Ablation Market
20.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Interventional Tumor Ablation Market
21.1. Eastern Europe Interventional Tumor Ablation Market Overview
21.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Interventional Tumor Ablation Market
22.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Interventional Tumor Ablation Market
23.1. North America Interventional Tumor Ablation Market Overview
23.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Interventional Tumor Ablation Market
24.1. USA Interventional Tumor Ablation Market Overview
24.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Interventional Tumor Ablation Market
26.1. South America Interventional Tumor Ablation Market Overview
26.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Interventional Tumor Ablation Market
27.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Interventional Tumor Ablation Market
28.1. Middle East Interventional Tumor Ablation Market Overview
28.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Interventional Tumor Ablation Market
29.1. Africa Interventional Tumor Ablation Market Overview
29.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles
